Skip to main content

George Yancopoulos

Analyst

Equibles does not estimate personal net worth.

About George Yancopoulos

George Yancopoulos has spoken on 1 earnings call across 1 company, most recently for Regeneron Pharmaceuticals, Inc. on July 30, 2026. The companies whose calls George Yancopoulos spoke on are classified in the Healthcare sector.

George Yancopoulos on recent calls

“Today, I'll focus on the key updates from our development pipeline. For a comprehensive summary of our mid- and late-stage pipelines, please refer to the Programs and Clinical Development section of our 10-Q. I'll start with our complement-mediated disease franchise, beginning with Cymdicerine, our C5-SIRNA.”
Regeneron Pharmaceuticals, Inc. Q2 FY2026 Earnings Call ·

Company network

Recent activity